Change in mammographic breast density associated with the use of Depo-Provera

Breast Journal

Volumn 9, Issue 4, 2003, Pages 312-315

  Dillis, Charlotte L ^a   Schreiman, Judith S ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Breast cancer; Breast density; Depo Provera; Mammography

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADULT; BREAST CANCER; BREAST DENSITY; CANCER RISK; CASE REPORT; DENSITY; FEMALE; FOLLOW UP; HORMONAL CONTRACEPTION; HUMAN; MAMMOGRAPHY; REVIEW;

ADULT; BREAST; CONTRACEPTIVE AGENTS, FEMALE; FEMALE; HUMANS; MAMMOGRAPHY; MEDROXYPROGESTERONE 17-ACETATE; MIDDLE AGED; PROGESTERONE CONGENERS;

EID: 0042666904     PISSN: 1075122X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4741.2003.09413.x     Document Type: Review

References (14)

1. Kopans DB. Breast Imaging, 2nd ed. Philadelphia: Lippincott-Raven, 1998.
2. White E, Velentgas P, Mandelson MT, et al. Variation in mammographic breast density by time in menstrual cycle among women aged 40-49 years. J Natl Cancer Inst 1998;90:906-10.
3. Physicians' Desk Reference. Montvale, NJ: Thomson Healthcare 2001:2596-98.
4. Spicer DV, Ursin G, Parisky YR, et al. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst 1994;86:431-36.
5. Brisson J, Brisson B, Cote G, Maunsell E, Berube S, Robert J. Tamoxifen and mammographic breast densities. Cancer Epidemiol Biomarkers Prev 2000;9:911-15.
6. Euhus DM, Uyehara C. Influence of parenteral progesterones on the prevalence and severity of mastalgia in premenopausal women: a multi-institutional cross-sectional study. J Am Coll Surg 1997;184:596-604.
7. McNicholas MM, Heneghan JP, Milner MH, Tunney T, Hourihane JB, MacErlaine DP. Pain and increased mammographic density in women receiving hormone replacement therapy: a prospective study. AJR Am J Roentgenol 1994;163:311-15.
8. Westhoff C. Contraception at age 35 years and older. Clin Obstet Gynecol 1998;41:951-57.
9. Laya MB, Gallagher JC, Schreiman JS, Larson EB, Watson P, Weinstein L. Effect of postmenopausal hormonal replacement therapy on mammographic density and parenchymal pattern. Radiology 1995;196:433-37.
10. Byng JW, Yaffe MJ, Jong RA, et al. Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics 1998;18:1587-98.
11. Shapiro S, Rosenberg L, Hoffman M, et al. Risk of breast cancer in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives. Am J Epidemiol 2000;151:396-403.
12. Skegg DC, Noonan EA, Paul C, Spears GF, Meirik O, Thomas DB. Depot medroxyprogesterone acetate and breast cancer. A pooled analysis of the World Health Organization and New Zealand studies. JAMA 1995;273:799-804.
13. Physicians' Desk Reference. Montvale, NJ: Thomson Healthcare 2001:3407.
14. Physicians' Desk Reference. Montvale, NJ: Thomson Healthcare 2001:2850.